Dr. Federico Steiner is a senior clinical research fellow in thoracic surgery at NYU Medical Center. His clinical responsibilities include performing thoracic surgery cases at NYU Tisch Hospital, Manhattan VA Hospital, Bellevue Hospital, and Beekman Downtown Hospital alongside the various faculty members of the Division of Thoracic Surgery. He will receive operative training in a large variety of procedures involving benign thoracic conditions as well as procedures for malignant disease using minimally invasive thoracoscopic, laparoscopic, and endoscopic techniques. His operative training will involve interventional procedures such as esophageal and airway stent placement, as well as the latest technologies applied to thoracic surgery such as radiofrequency ablation (RFA) and photodynamic therapy (PDT) surgery for thoracic malignancies.
During his surgery residency, Dr. Steiner completed a two-year clinical research fellowship in surgical oncology at the National Institutes of Health (NIH) and conducted research in epigenetics and gene induction in lung cancer, esophageal cancer, and mesothelioma. His involvement in NIH clinical trials and conducting basic science research with the NIH Thoracic Surgery Division has provided him with the necessary foundation to continue work in elucidating mechanisms of tumor progression and discovery of tumor markers. In the NYU Thoracic Surgery laboratory, he is currently focusing on hypoxia mediated pathways of tumor progression and discovery of tumor prognostic markers in malignant pleural mesothelioma.
Dr. Steiner has been accepted to the NYU Masters Program in Clinical Investigation and will spend his time outside the operating room and research laboratory taking part in seminars that will ultimately prepare him for a career in academic Thoracic Surgery involving translational research. His interest is to conduct basic science research in thoracic malignancies and apply a bench-to-bedside approach using discoveries in the laboratory and applying them in the clinical setting in an effort to conduct clinical trials in thoracic oncology.